The Future of TB Prevention: A Turning Point in Global Health

As the world’s deadliest infectious disease, tuberculosis continues to claim millions of lives—despite being both preventable and curable. But the tide may soon turn. For the first time in over a century, a new generation of TB vaccines is within reach.

Mycobacterium Tuberculosis Bacteria Scanning electron micrograph. Credit: National Institute of Allergy and Infectious Diseases on Unsplash.

This article, originally published by VaccinesWork, highlights promising candidates like the M72 vaccine, now in Phase 3 trials across high-burden countries including Kenya, Malawi, South Africa, Zambia, and Indonesia. If successful, these vaccines could dramatically reduce TB deaths and transmission—particularly among adolescents and adults, who account for the majority of cases.

Read on below or view the original article on VaccinesWork